Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study. 1982

D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females

Related Publications

D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
September 1995, European journal of cancer (Oxford, England : 1990),
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
January 1988, Oncology,
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
January 1992, Anticancer research,
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
January 1983, Bulletin du cancer,
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
September 1987, European journal of cancer & clinical oncology,
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
January 1988, Cancer investigation,
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
August 2004, Journal of cancer research and clinical oncology,
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
September 1991, British journal of cancer,
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
December 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
D Machover, and L Schwarzenberg, and E Goldschmidt, and J M Tourani, and B Michalski, and M Hayat, and T Dorval, and J L Misset, and C Jasmin, and R Maral, and G Mathé
August 1995, Anti-cancer drugs,
Copied contents to your clipboard!